We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AAREYDRUGS.NSE

Price
55.23
Stock movement up
+2.63 (5.00%)
Company name
Aarey Drugs & Pharmaceuticals Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
1.57B
Ent value
2.94B
Price/Sales
0.30
Price/Book
1.15
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
22.71
Forward P/E
-
PEG
-
EPS growth
-9.81%
1 year return
15.30%
3 year return
9.82%
5 year return
-
10 year return
-
Last updated: 2025-04-17

DIVIDENDS

AAREYDRUGS.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E22.71
Price to OCF165.89
Price to FCF165.89
Price to EBITDA57.93
EV to EBITDA108.78

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.30
Price to Book1.15
EV to Sales0.57

FINANCIALS

Per share

Loading...
Per share data
Current share count28.35M
EPS (TTM)2.46
FCF per share (TTM)0.34

Income statement

Loading...
Income statement data
Revenue (TTM)5.19B
Gross profit (TTM)163.00M
Operating income (TTM)62.10M
Net income (TTM)68.95M
EPS (TTM)2.46
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)3.14%
Operating margin (TTM)1.20%
Profit margin (TTM)1.33%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash14.90M
Net receivables0.00
Total current assets2.51B
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.75B
Accounts payable849.77M
Short/Current long term debt386.50M
Total current liabilities1.38B
Total liabilities1.39B
Shareholder's equity1.36B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)9.44M
Capital expenditures (TTM)0.00
Free cash flow (TTM)9.44M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity5.09%
Return on Assets2.51%
Return on Invested Capital3.96%
Cash Return on Invested Capital0.54%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open55.05
Daily high55.23
Daily low52.70
Daily Volume58K
All-time high73.61
1y analyst estimate-
Beta0.92
EPS (TTM)2.46
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
AAREYDRUGS.NSES&P500
Current price drop from All-time high-24.97%-14.24%
Highest price drop-63.10%-56.47%
Date of highest drop28 Mar 20239 Mar 2009
Avg drop from high-29.44%-11.07%
Avg time to new high83 days12 days
Max time to new high483 days1805 days
COMPANY DETAILS
AAREYDRUGS.NSE (Aarey Drugs & Pharmaceuticals Limited) company logo
Marketcap
1.57B
Marketcap category
Small-cap
Description
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. In addition, the company trades in industrial solvents and chemicals.The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.
Employees
0
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found